Resultado de búsqueda
Hace 1 día · El miércoles, Forte Biosciences Inc. (NASDAQ: ... El FB-102 se dirige al CD-122, un componente de los receptores IL-2 e IL-15, cruciales en la regulación de las células T NK CD8+ y tregs.
Hace 8 horas · The broad-based S&P 500 declined 0.7 per cent to 5,266.95, while the tech-rich Nasdaq Composite Index dropped 0.6 per cent to 16,920.58. Analysts have attributed the rise in Treasury yields partly ...
Hace 1 día · Forte Biosciences Inc. (NASDAQ:FBRX) FB-102 için klinik çalışmalarında ilerlerken, yatırımcıların şirketin finansal sağlığını ve piyasa performansını göz önünde bulundurması önemlidir. Özellikle, Forte Biosciences bilançosunda borçtan daha fazla nakit bulunduruyor, ...
Hace 8 horas · LEO Pharma, laboratorio farmacéutico especializado en medicamentos para dermatología médica y trombosis, gana presencia en el mercado español. La compañía elevó sus ingresos en España un 6 ...
Hace 8 horas · Futures contracts for US equities also slipped in Asian trading after the S&P 500 ended on Wednesday back below 5,300, while the Nasdaq 100 had its worst day since 1 May. Treasuries steadied on ...
Hace 1 día · On Wednesday, Forte Biosciences Inc. (NASDAQ :FBRX) received a positive outlook from Brookline Capital Markets, as the firm initiated coverage with a Buy rating and a stock price target of $4.00.The firm's analyst highlighted the potential of Forte Biosciences' FB-102, an antibody in development for the treatment of graft versus host disease (GVHD).
Hace 8 horas · CAMARILLO, CA, – Sacks Parente Golf Company, Inc. (Nasdaq: SPGC) (“SPG” or the “Company”), a technology forward golf company with a growing portfolio of golf products, including putters, golf shafts, golf grips, and other related accessories, announces the launch of a Weekly Performance Pool program for players on the PGA TOUR Champions using Newton Motion driver shafts.
